UBS Group’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-184,891
| Closed | -$324K | – | 9286 |
|
2025
Q1 | $324K | Buy |
184,891
+94,744
| +105% | +$166K | ﹤0.01% | 4973 |
|
2024
Q4 | $142K | Buy |
90,147
+60,271
| +202% | +$95.2K | ﹤0.01% | 5457 |
|
2024
Q3 | $46.9K | Buy |
29,876
+10,659
| +55% | +$16.7K | ﹤0.01% | 5662 |
|
2024
Q2 | $34.3K | Buy |
19,217
+18,915
| +6,263% | +$33.8K | ﹤0.01% | 5828 |
|
2024
Q1 | $870 | Sell |
302
-42
| -12% | -$121 | ﹤0.01% | 7154 |
|
2023
Q4 | $440 | Sell |
344
-64
| -16% | -$82 | ﹤0.01% | 7440 |
|
2023
Q3 | $558 | Sell |
408
-3,204
| -89% | -$4.38K | ﹤0.01% | 7258 |
|
2023
Q2 | $5.31K | Buy |
3,612
+1,874
| +108% | +$2.76K | ﹤0.01% | 6375 |
|
2023
Q1 | $1.47K | Sell |
1,738
-3,924
| -69% | -$3.33K | ﹤0.01% | 7628 |
|
2022
Q4 | $7.76K | Sell |
5,662
-4,514
| -44% | -$6.18K | ﹤0.01% | 7670 |
|
2022
Q3 | $17K | Buy |
10,176
+1,924
| +23% | +$3.21K | ﹤0.01% | 6519 |
|
2022
Q2 | $17K | Buy |
8,252
+2,081
| +34% | +$4.29K | ﹤0.01% | 6074 |
|
2022
Q1 | $18K | Buy |
6,171
+3,776
| +158% | +$11K | ﹤0.01% | 6538 |
|
2021
Q4 | $8K | Buy |
2,395
+408
| +21% | +$1.36K | ﹤0.01% | 7929 |
|
2021
Q3 | $14K | Buy |
+1,987
| New | +$14K | ﹤0.01% | 6454 |
|
2021
Q1 | – | Sell |
-280
| Closed | -$4K | – | 8172 |
|
2020
Q4 | $4K | Buy |
+280
| New | +$4K | ﹤0.01% | 6895 |
|
2020
Q3 | – | Sell |
-90
| Closed | -$1K | – | 7339 |
|
2020
Q2 | $1K | Buy |
+90
| New | +$1K | ﹤0.01% | 6933 |
|
2020
Q1 | – | Sell |
-819
| Closed | -$7K | – | 7184 |
|
2019
Q4 | $7K | Sell |
819
-859
| -51% | -$7.34K | ﹤0.01% | 6381 |
|
2019
Q3 | $12K | Buy |
+1,678
| New | +$12K | ﹤0.01% | 6092 |
|
2019
Q2 | – | Sell |
-197
| Closed | -$2K | – | 7110 |
|
2019
Q1 | $2K | Buy |
197
+103
| +110% | +$1.05K | ﹤0.01% | 6626 |
|
2018
Q4 | $1K | Sell |
94
-40
| -30% | -$426 | ﹤0.01% | 6980 |
|
2018
Q3 | $3K | Buy |
134
+9
| +7% | +$201 | ﹤0.01% | 6732 |
|
2018
Q2 | $10K | Buy |
+125
| New | +$10K | ﹤0.01% | 6219 |
|
2018
Q1 | – | Sell |
-153
| Closed | -$19K | – | 7032 |
|
2017
Q4 | $19K | Buy |
153
+150
| +5,000% | +$18.6K | ﹤0.01% | 5632 |
|
2017
Q3 | $0 | Sell |
3
-258
| -99% | – | ﹤0.01% | 6878 |
|
2017
Q2 | $31K | Sell |
261
-49
| -16% | -$5.82K | ﹤0.01% | 5066 |
|
2017
Q1 | $61K | Buy |
310
+20
| +7% | +$3.94K | ﹤0.01% | 4488 |
|
2016
Q4 | $78K | Buy |
290
+72
| +33% | +$19.4K | ﹤0.01% | 4576 |
|
2016
Q3 | $86K | Sell |
218
-51
| -19% | -$20.1K | ﹤0.01% | 4232 |
|
2016
Q2 | $92K | Buy |
269
+11
| +4% | +$3.76K | ﹤0.01% | 4261 |
|
2016
Q1 | $214K | Buy |
258
+136
| +111% | +$113K | ﹤0.01% | 3737 |
|
2015
Q4 | $127K | Buy |
122
+41
| +51% | +$42.7K | ﹤0.01% | 4075 |
|
2015
Q3 | $64K | Buy |
81
+14
| +21% | +$11.1K | ﹤0.01% | 4518 |
|
2015
Q2 | $88K | Buy |
67
+12
| +22% | +$15.8K | ﹤0.01% | 4380 |
|
2015
Q1 | $112K | Buy |
55
+47
| +588% | +$95.7K | ﹤0.01% | 4119 |
|
2014
Q4 | $16K | Buy |
+8
| New | +$16K | ﹤0.01% | 5739 |
|